Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus
about
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infectionCholera toxin: a paradigm of a multifunctional proteinOral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice.Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.Effect of cholera toxin on vaccine-induced immunity and infection in murine schistosomiasis mansoniInhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunitProtective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.CpG-B oligodeoxynucleotides inhibit TLR-dependent and -independent induction of type I IFN in dendritic cells.Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines.Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition.Progress towards development of a vaccine for amebiasis.Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.Local and systemic antibody responses to dextran-cholera toxin B subunit conjugatesAnticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxinRabies ribonucleocapsid as an oral immunogen and immunological enhancerCholera toxin as a mucosal adjuvant: effects of H-2 major histocompatibility complex and lps genes.Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein.Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunitMouse models for the study of mucosal vaccination against otitis media.Intracellular neutralization of virus by immunoglobulin A antibodiesEnhancing effect of cholera toxin on interleukin-6 secretion by IEC-6 intestinal epithelial cells: mode of action and augmenting effect of inflammatory cytokines.Secretory immunoglobulin A response to Shiga toxin in rabbits: kinetics of the initial mucosal immune response and inhibition of toxicity in vitro and in vivo.Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide.T cell cytokine polarity as a determinant of immunoglobulin A (IgA) glycosylation and the severity of experimental IgA nephropathy.
P2860
Q24548763-6E77C244-7130-4D67-B58F-084D84F9F8EBQ24598726-524DC89A-9DD4-4082-BC0B-7B33E46DB11EQ33597025-398D5D4B-3096-42D0-8267-BB532C55B27FQ33611155-89FE783B-F727-4A71-9225-A16B80B10BA5Q33615306-BADA8724-38A4-480D-84E2-6A4F5B82E619Q33757092-0D6E7D4D-D63F-4002-8BEA-319EE67A1F77Q33845547-25EC4213-BFCF-4F77-8D78-7B229729D066Q33944310-38CD01FA-0A30-417D-BB93-9212DC4803B5Q34520511-1BE867CB-1393-40B9-971C-BFA7E0F4E3F5Q34522325-0F0700C2-4440-4433-8E8C-452EEBCBC537Q34522757-7CC18631-9E12-4662-BAF6-3550B5036745Q35375735-C3148E5D-2EA2-418D-BE1B-FBD26E437AADQ35400277-E58ADB65-9D8C-41D7-90EB-9DA6900A6FAFQ35413377-DB2E144E-AB5B-4114-A5BA-1FF82302DCF0Q35546011-04CB04AF-4178-40C5-A0F8-A234A8447226Q35559595-172A2362-555A-44CE-9880-BD58B87F0D01Q35884939-328E8813-8C0D-4D65-BD67-0667E8E681D9Q36947860-544BCDB2-E56A-4ABC-AB28-D36A21E7FEC0Q36975393-A91E2224-7DA0-47C7-BC2A-115310320F22Q36989025-A340BDF7-4522-42A9-9065-979390ACB7F0Q37093093-F4A9D03A-C511-4FB7-9E61-81F690D05672Q37126877-EE31609B-3E3D-477B-BEF8-84640266B014Q40269379-C2EC5013-1B6B-4146-B890-1EEE759CC0AFQ40429422-C2DA56D7-6683-49E2-9C3F-A45D0E30F2FEQ42844055-C19FA5A8-35ED-4CB0-9FC1-215D097E68DEQ46476267-75487C15-B402-4AC0-A564-4D9BBAB521FC
P2860
Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus
description
1988 nî lūn-bûn
@nan
1988 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
name
Oral administration of cholera ...... immunity against Sendai virus
@ast
Oral administration of cholera ...... immunity against Sendai virus
@en
Oral administration of cholera ...... immunity against Sendai virus
@nl
type
label
Oral administration of cholera ...... immunity against Sendai virus
@ast
Oral administration of cholera ...... immunity against Sendai virus
@en
Oral administration of cholera ...... immunity against Sendai virus
@nl
prefLabel
Oral administration of cholera ...... immunity against Sendai virus
@ast
Oral administration of cholera ...... immunity against Sendai virus
@en
Oral administration of cholera ...... immunity against Sendai virus
@nl
P2093
P1476
Oral administration of cholera ...... immunity against Sendai virus
@en
P2093
P304
P407
P577
1988-09-01T00:00:00Z